On June 1, 2011
Pfizer May Cut Loose Its Generics Unit Despite Doubts It Can Thrive on Its Own
Established product revenues sank 15 percent to $2.4 billion in Q1 2011. Greenstone may need Pfizer more than Pfizer needs Greenstone — which is why there’s talk of cutting it loose.
No tags for this post.
0 Comments